Independent
Tenure on this board
5.1 yrs
Also a director at
Servicetitan Inc (TTAN)Veeva Systems Inc (VEEV)
Meeting calendar
DOCS · Annual meeting · Thursday, August 27, 2026
Doximity Inc
2 nominees · 3 ballot items.
Election of two Class II directors; ratification of Deloitte & Touche LLP as independent auditors; and a non-binding advisory vote to approve executive compensation (Say-on-Pay).
Market cap
$4.1B
1Y TSR
-65.0%
Board grade
C-
Record date
Jul 2, 2026
Filing
DEF 14A
Filed Jul 15, 2026 · DEF 14A
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect two Class II directors (Kevin Spain and Timothy Cabral) to serve until the 2029 annual meeting or until successors qualify.
- 2
Ratification of the Appointment of Our Independent Registered Public Accounting Firm
ManagementBoard: FORRatify Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending March 31, 2027.
- 3
Non-Binding Advisory Vote on the Compensation of Our Named Executive Officers (Say-on-Pay
ManagementBoard: FORNon-binding, advisory vote to approve the compensation of the company's named executive officers as disclosed in the proxy statement for fiscal year 2026.
Director elections
Nominees on the ballot2
Independent
Tenure on this board
5.1 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.5% | 8,262,475 | $193M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.5% | 6,394,107 | $149M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.2% | 5,765,063 | $134M |
| 4 | Clearbridge Investments, LLC | 2.7% | 4,975,398 | $116M |
| 5 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.6% | 4,834,220 | $113M |
| 6 | Carmignac Gestion | 2.4% | 4,311,997 | $100M |
| 7 | BlackRock, Inc. | 2.2% | 4,099,735 | $96M |
| 8 | STATE STREET CORP | 2.2% | 4,039,510 | $94M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 3,448,788 | $80M |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 1.7% | 3,059,749 | $71M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Doximity Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.5B
Haemonetics CorpHAE
Annual meeting·Jul 24, 2026·$3.5B
Amneal Pharmaceuticals IncAMRX
Special meeting·Jul 31, 2026·$5.5B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.3B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.7B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.6B
Reference
Frequently asked questions
- When is the Doximity Inc 2026 annual meeting?
- Doximity Inc (DOCS) holds its 2026 annual shareholder meeting on Thursday, August 27, 2026.
- What is the record date for the Doximity Inc 2026 meeting?
- The record date for the Doximity Inc 2026 meeting is Thursday, July 2, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Doximity Inc's 2026 meeting?
- The board is presenting 2 director nominees at the Doximity Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Doximity Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Doximity Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.